期刊文献+

癌症治疗药物埃罗替尼的合成 被引量:2

The Synthesis of Cancer Treatment Medicine Erlotinib
原文传递
导出
摘要 提供了一种埃罗替尼的制备方法,该方法以3,4-二羟基苯甲酸乙酯为起始原料,经过与乙二醇单甲醚的醚化反应,再经硝化、还原、缩合成环,然后经卤化与间氨基苯乙炔反应,最后通入干燥的氯化氢气体后生成埃罗替尼。其中,硝化工艺相比于以前的工艺有较大的改进。本合成路线具有反应条件温和、总收率好、后处理简便易行和易于进行工业化生产等优点。 The concise synthesis of Erlotinib was described. Treatment of Ethyl 3,4-dihydroxybenzoate with 2-methoxyethyl methanesulfonate followed by nitration, reduction, cyclization and chloration to afford d-chloro-6,7-his (2-methoxyethoxy)-1,d- dihydroquinazoline, which was treated with 3-ethynylaniline and then with dry hydrochloride to give Erlotinib. In this synthesis, the nitration process has greatly been improved. The advantages of this synthetic route include short reaction time, good total yield, and simple work-up.
出处 《科技导报》 CAS CSCD 北大核心 2012年第5期49-51,共3页 Science & Technology Review
关键词 埃罗替尼 硝化 合成 Erlotinib nitration synthesis
  • 相关文献

参考文献5

  • 1Adjei A A. Epidemal growth factor receptor tyrosine kinase inhihitors in cancer therapy[J]. Drugs of the Future, 2001, 26(11): 1087-1092.
  • 2Jyothi P R, Nageshwar R B, Venkaiah C N. Novel process for the preparation of Ertotinih. United States, 2009/0306377A1 [ P]. 2009-12- 10.
  • 3徐浩,栗思存,黄文龙,郭青龙,高源.埃罗替尼衍生物的合成及抗肿瘤活性[J].中国药科大学学报,2008,39(6):487-490. 被引量:7
  • 4Knesl P Riiseling D, Jordis tJ. Improved synthesis of substituted 6,7- dihydroxy-4-quinazolineamines: Tandulinib, Erlotinih trod Gefitinilb[J]. Molecules, 2006, 11(4): 286-297.
  • 5两野繁荣,弘津健二,岛秀好,等.制备6,7-二(2一Ffl氧基乙氧基)喹唑啉-4-酮的方法.中阁,1860105[P].2006-11-08.

二级参考文献8

  • 1Adjei AA. Epidermal growth factor receptor tyrosine kinase inhibitors in cancer therapy [ J ]. Drugs Future,2001,26 ( 11 ) : 1 087 - 1 092.
  • 2Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture [ J ]. Eur J Cancer, 2001,37 ( Suppl 8 ) : S4 -66.
  • 3Vlahovic G, Crawford J. Activation of tyrosine kinases in cancer [J]. Oncologist,2003,8(6) :531 -538.
  • 4Basegla J, Hammond LA. HER-targeted tyrosine-kinase inhibitors [ J ]. Oncology,2002,63 ( Suppl 1 ) : S6 - 16.
  • 5Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in nonsmall cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials [ J ]. BMJ,1995,311(7 010) :899 -909.
  • 6Stamos J, Sliwkowski MX, Eigenbrot C. Structure of the EGF Receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor[ J ]. J Biol Chem, 2002,277 ( 48 ) : 46 265 - 46 272.
  • 7Knesl P, Roseling D,Jordis U. Improved synthesis of substituted 6,7-Dihydroxy-4-quinazolineamines : tandutinib, erlotinib and gefitinib [ J ] . Molecules,2006,11 ( 4 ) : 286 - 297.
  • 8Orfi L, Waczek F, Pato J, et al. Improved, high yield synthesis of 3H-quinazolin-4-ones, the key intermediates of recently developed drugs[J]. Curr Med Chem,2004,11(19) :2 549 -2 553.

共引文献6

同被引文献26

  • 1刘敏,胡昌勤.力达霉素标准品量值传递方法的研究[J].药物分析杂志,2004,24(4):380-384. 被引量:14
  • 2李铭东,曹萌,吉民.盐酸埃洛替尼的合成[J].中国医药工业杂志,2007,38(4):257-259. 被引量:10
  • 3中国药典2010年版.二部[S].2010:附录29.
  • 4Schnur RC ,Arnold LD. Quinazoline derivatives[ P]. W01996030347, 1996-10-03. ( CA1996,125:328728).
  • 5Schnur RC, Arnold LD. Alkynyl and azid- o- substitubed 4- anilinoquinazolines[ P]. US5747498, 1998 -05 -05. ( CA1998,128 : 321653 ).
  • 6Petr Knesl, Dirk Roseling, Ulrich Jordis. Improved Synthesis of Substituted 6,7-Dihydroxy-4-quinazolineamines : Tandutinib, Erlotinib and Gefitlnib[ J]. Molecules,2006 ( 11 ) :286-297.
  • 7Kae-Sh yang Shih, Yu- Jung Hsieh, Ching- Wei Liu. Method of Synthesizing 6,7 - substituded - 4anilino quinazoline [ P ]. US: 201002679P,2010-10-21.
  • 8Chandregowda, Venkateshappa, Rao, Gudapati Venkateswara. One- pot conversion of 2 - nitrobenzonitriles to quinazolin - 4 ( 3H ) - ones and synthesis of gefitinib and erlotinib hydrochloride [ J ]. Heterocycles, 2007,71 ( 1 ) :39-48.
  • 9Chandregowda, Venkateshappa, Rao, Gudapati. A process for synthesiss of [ 6, 7 - bis - ( 2 - methoxyethoxy ) - quinazolin - 4 - yl ] - ( 3 - ethynylphenyl) amine hydrochloride ( eriotinib hydrochlofide ) [ P ]. IN2005 CH01483 ( CA2008,148:495978 ).
  • 10Venkateshappa Chandregowda, Gudapati Venkateswara Rao. etal. Convergent aPPROACH FOR Commercial Synthesis of Gefitinib and Eriotinib [ J ]. Organic Process Research&Development. 2007,11 : 813 - 816.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部